Tissue eosinophilia: Not an indicator of drug-induced subacute cutaneous lupus erythematosus

Archives of Dermatology

Volumn 148, Issue 2, 2012, Pages 190-193

  Hillesheim, Paul B ^a   Bahrami, Soon ^a   Jeffy, Brooke G ^a   Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMLODIPINE PLUS BENAZEPRIL; BUSPIRONE; CELECOXIB; CORTICOSTEROID; DILTIAZEM; DOXORUBICIN; FENOFIBRATE; HYDROXYCHLOROQUINE SULFATE; INDAPAMIDE; MUCIN; PACLITAXEL; PREDNISONE; PREGABALIN; ROSUVASTATIN; TERBINAFINE;

ADULT; AGED; ARTICLE; BASAL LAYER LIQUEFACTION; BASEMENT MEMBRANE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG INDUCED DISEASE; DRUG INDUCED SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS; DRUG WITHDRAWAL; DYSKERATOSIS; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIADNEXAL INFLAMMATION; PRIORITY JOURNAL; SHORT COURSE THERAPY; SKIN LUPUS ERYTHEMATOSUS; TISSUE EOSINOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DRUG ERUPTIONS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; MUCINS; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84857405544     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.290     Document Type: Article

References (9)

1. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med. 1985;103(1):49-51. (Pubitemid 15068498)
2. Callen JP. Drug-induced subacute cutaneous lupus erythematosus. Lupus. 2010;19(9):1107-1111.
3. Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139(1):45-49. (Pubitemid 36091573)
4. Lowe G, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011;164(3):465-472.
5. Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch Dermatol. 2001;137(9):1196-1198. (Pubitemid 32847842)
6. Funke AA, Kulp-Shorten CL, Callen JP. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy. Arch Dermatol. 2010;146(10):1113-1116.
7. Bahrami S, Malone J, Webb K, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol. 2006;142(2):155-161. (Pubitemid 43276527)
8. Marzano AV, Lazzari R, Polloni I, Crosti C, Fabbri P, Cugno M. Drug-induced sub-acute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart. Br J Dermatol. 2011;165(2):335-341.
9. Cassis TB, Callen JP. Bupropion-induced subacute cutaneous lupus erythematosus. Australas J Dermatol. 2005;46(4):266-269. (Pubitemid 43942716)